Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia

Author： Kaplan S.A. Holtgrewe H.L. Bruskewitz R. Saltzman B. Mobley D. Narayan P. Lund R.H. Weiner S. Wells G. Cook T.J. Meehan A. Waldstreicher J. for the Proscar Long-Term Efficacy and Safety Study Group

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.57, Iss.6, 2001-06, pp. : 1073-1077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting

By Keetch D.W. Andriole G.L. Ratliff T.L. Catalona W.J.

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 901-905

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

By Roehrborn C.G. Boyle P. Nickel J.C. Hoefner K. Andriole G. the ARIA3001 ARIA3002 and ARIA3003 Study Investigators

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 434-441

Elsevier

Access to resources Recommend Favorite

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia

By Lepor H.

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 406-413

Elsevier

Access to resources Recommend Favorite

Effect of finasteride on serum testosterone in men with benign prostatic hyperplasia and low testosterone levels

By Roehrborn C. PLESS Study Group

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 160-160

Elsevier

Access to resources Recommend Favorite

Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

By Lam J.S. Romas N.A. Lowe F.C.

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite